Zi-Han Gao Selected Research

GAL021

1/2020

High Efficacy by GAL-021: A Known Intravenous Peripheral Chemoreceptor Modulator that Suppresses BKCa-Channel Activity and Inhibits IK(M) or Ih.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zi-Han Gao Research Topics

Disease

3	Pituitary Neoplasms (Pituitary Adenoma) 01/2020 - 11/2019
1	Fibrosis (Cirrhosis) 03/2020
1	Coronavirus Infections 01/2020
1	Hypoxia (Hypoxemia) 11/2019
1	Necrosis 07/2019
1	Neoplasms (Cancer) 07/2019
1	Inflammation (Inflammations) 07/2019
1	Unstable Angina 12/2014

Drug/Important Bio-Agent (IBA)

1	remdesivirIBA 01/2020
1	GAL021IBA 01/2020
1	Antiviral Agents (Antivirals)IBA 01/2020
1	NucleotidesIBA 01/2020
1	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 11/2019
1	roxadustatIBA 11/2019
1	Ketoglutaric Acids (Ketoglutaric Acid)IBA 11/2019
1	CationsIBA 11/2019
1	ImmunosorbentsIBA 07/2019
1	EnzymesIBA 07/2019
1	saikosaponin DIBA 07/2019

Therapy/Procedure

1	Transplantation 03/2020
1	Percutaneous Coronary Intervention 12/2014